SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-001265
Filing Date
2017-03-06
Accepted
2017-03-06 08:00:59
Documents
6
Period of Report
2017-04-17
Effectiveness Date
2017-03-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2231097zdef14a.htm DEF 14A 485877
2 G560220.JPG g560220.jpg GRAPHIC 25227
3 G785187.JPG g785187.jpg GRAPHIC 4239
4 G140562.JPG g140562.jpg GRAPHIC 4845
5 G22322BGI001.GIF g22322bgi001.gif GRAPHIC 92632
6 G22322BGI002.GIF g22322bgi002.gif GRAPHIC 112307
  Complete submission text file 0001047469-17-001265.txt   817093
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35986 | Film No.: 17666501
SIC: 2834 Pharmaceutical Preparations